Logo image of ALKEY.PA

KEYRUS (ALKEY.PA) Stock Fundamental Analysis

EPA:ALKEY - Euronext Paris - Matif - FR0004029411 - Common Stock - Currency: EUR

7.5  +0.01 (+0.13%)

Fundamental Rating

1

Taking everything into account, ALKEY scores 1 out of 10 in our fundamental rating. ALKEY was compared to 69 industry peers in the IT Services industry. ALKEY may be in some trouble as it scores bad on both profitability and health. ALKEY does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALKEY has reported negative net income.
ALKEY had a positive operating cash flow in the past year.
In multiple years ALKEY reported negative net income over the last 5 years.
Each year in the past 5 years ALKEY had a positive operating cash flow.
ALKEY.PA Yearly Net Income VS EBIT VS OCF VS FCFALKEY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M 50M

1.2 Ratios

ALKEY's Return On Assets of -0.54% is on the low side compared to the rest of the industry. ALKEY is outperformed by 63.77% of its industry peers.
ALKEY has a worse Return On Equity (-4.16%) than 63.77% of its industry peers.
ALKEY has a worse Return On Invested Capital (5.44%) than 62.32% of its industry peers.
ALKEY had an Average Return On Invested Capital over the past 3 years of 5.58%. This is significantly below the industry average of 10.77%.
Industry RankSector Rank
ROA -0.54%
ROE -4.16%
ROIC 5.44%
ROA(3y)1.12%
ROA(5y)0.22%
ROE(3y)9.2%
ROE(5y)2.91%
ROIC(3y)5.58%
ROIC(5y)4.54%
ALKEY.PA Yearly ROA, ROE, ROICALKEY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 15

1.3 Margins

In the last couple of years the Profit Margin of ALKEY has declined.
With a Operating Margin value of 3.95%, ALKEY perfoms like the industry average, outperforming 44.93% of the companies in the same industry.
In the last couple of years the Operating Margin of ALKEY has remained more or less at the same level.
The Gross Margin of ALKEY (63.30%) is comparable to the rest of the industry.
ALKEY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.95%
PM (TTM) N/A
GM 63.3%
OM growth 3Y16.42%
OM growth 5Y0.5%
PM growth 3YN/A
PM growth 5Y-21.83%
GM growth 3Y-2.32%
GM growth 5Y-0.01%
ALKEY.PA Yearly Profit, Operating, Gross MarginsALKEY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALKEY is destroying value.
ALKEY has about the same amout of shares outstanding than it did 1 year ago.
ALKEY has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALKEY has a worse debt to assets ratio.
ALKEY.PA Yearly Shares OutstandingALKEY.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ALKEY.PA Yearly Total Debt VS Total AssetsALKEY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 1.61, we must say that ALKEY is in the distress zone and has some risk of bankruptcy.
ALKEY's Altman-Z score of 1.61 is on the low side compared to the rest of the industry. ALKEY is outperformed by 69.57% of its industry peers.
ALKEY has a debt to FCF ratio of 4.61. This is a neutral value as ALKEY would need 4.61 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.61, ALKEY is in line with its industry, outperforming 46.38% of the companies in the same industry.
A Debt/Equity ratio of 1.77 is on the high side and indicates that ALKEY has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.77, ALKEY is doing worse than 78.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.77
Debt/FCF 4.61
Altman-Z 1.61
ROIC/WACC0.91
WACC5.98%
ALKEY.PA Yearly LT Debt VS Equity VS FCFALKEY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

ALKEY has a Current Ratio of 1.00. This is a bad value and indicates that ALKEY is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ALKEY (1.00) is worse than 69.57% of its industry peers.
A Quick Ratio of 1.00 indicates that ALKEY may have some problems paying its short term obligations.
ALKEY has a worse Quick ratio (1.00) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
ALKEY.PA Yearly Current Assets VS Current LiabilitesALKEY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALKEY have decreased strongly by -136.51% in the last year.
The earnings per share for ALKEY have been decreasing by -17.02% on average. This is quite bad
Looking at the last year, ALKEY shows a decrease in Revenue. The Revenue has decreased by -2.62% in the last year.
The Revenue has been growing slightly by 6.27% on average over the past years.
EPS 1Y (TTM)-136.51%
EPS 3YN/A
EPS 5Y-17.02%
EPS Q2Q%-179.75%
Revenue 1Y (TTM)-2.62%
Revenue growth 3Y12.38%
Revenue growth 5Y6.27%
Sales Q2Q%-4.62%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALKEY.PA Yearly Revenue VS EstimatesALKEY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALKEY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALKEY.PA Price Earnings VS Forward Price EarningsALKEY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALKEY indicates a somewhat cheap valuation: ALKEY is cheaper than 60.87% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ALKEY is valued cheaply inside the industry as 84.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.34
EV/EBITDA 7.96
ALKEY.PA Per share dataALKEY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALKEY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KEYRUS

EPA:ALKEY (5/8/2025, 7:00:00 PM)

7.5

+0.01 (+0.13%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-24 2025-04-24
Earnings (Next)N/A N/A
Inst Owners1.76%
Inst Owner ChangeN/A
Ins Owners85.52%
Ins Owner ChangeN/A
Market Cap129.60M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DP-24.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.36
P/FCF 6.34
P/OCF 5.75
P/B 3.06
P/tB N/A
EV/EBITDA 7.96
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.18
FCFY15.78%
OCF(TTM)1.31
OCFY17.4%
SpS20.93
BVpS2.45
TBVpS-3.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.54%
ROE -4.16%
ROCE 9.01%
ROIC 5.44%
ROICexc 7.43%
ROICexgc 45.79%
OM 3.95%
PM (TTM) N/A
GM 63.3%
FCFM 5.66%
ROA(3y)1.12%
ROA(5y)0.22%
ROE(3y)9.2%
ROE(5y)2.91%
ROIC(3y)5.58%
ROIC(5y)4.54%
ROICexc(3y)8.55%
ROICexc(5y)6.99%
ROICexgc(3y)70.15%
ROICexgc(5y)55.42%
ROCE(3y)9.25%
ROCE(5y)7.53%
ROICexcg growth 3Y8.83%
ROICexcg growth 5Y12.15%
ROICexc growth 3Y17.23%
ROICexc growth 5Y-1.56%
OM growth 3Y16.42%
OM growth 5Y0.5%
PM growth 3YN/A
PM growth 5Y-21.83%
GM growth 3Y-2.32%
GM growth 5Y-0.01%
F-Score4
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 1.77
Debt/FCF 4.61
Debt/EBITDA 3.28
Cap/Depr 24.73%
Cap/Sales 0.58%
Interest Coverage 2.21
Cash Conversion 98.96%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 1.61
F-Score4
WACC5.98%
ROIC/WACC0.91
Cap/Depr(3y)26.06%
Cap/Depr(5y)31.55%
Cap/Sales(3y)0.76%
Cap/Sales(5y)1.11%
Profit Quality(3y)409.78%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.51%
EPS 3YN/A
EPS 5Y-17.02%
EPS Q2Q%-179.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.62%
Revenue growth 3Y12.38%
Revenue growth 5Y6.27%
Sales Q2Q%-4.62%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.59%
EBIT growth 3Y30.83%
EBIT growth 5Y6.81%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y66.32%
FCF growth 3Y-25.62%
FCF growth 5YN/A
OCF growth 1Y48.1%
OCF growth 3Y-25.51%
OCF growth 5Y223.07%